MFine
Buying intent
22 tracked signals | Top 15 topics are below | Operations and Support are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere MFine's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
13d ago
13d ago
30d ago
27d ago
31d ago
13d ago
13d ago
23d ago
27d ago
13d ago
29d ago
23d ago
13d ago
13d ago
13d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at MFine
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileWe strongly believe that consulting with your trusted doctor should not be as complicated and time-consuming as it is today! Scheduling an appointment, taking the day off work, waiting at the clinic for hours can all prove to be extremely tiresome, especially when you are feeling under the weather. MFine aims to make your access to trusted healthcare simple, fast, and effective. We believe in imp
Top accounts researching MFine
names withheld on the public pageThese are companies whose own people brought up MFine unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
5,181 companies · 17,564 people are researching Healthcare Interoperability
MFine's own team shows 2 signals on this topic. No one outside MFine has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Healthcare Operations827 cos · 2,776 people
- T cells311 cos · 979 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 1 person; HR / Talent — 1 person; Customer Success — 1 person; Operations — 1 person
What's been said
public posts by MFine's teamNo public post naming MFine has surfaced in the past year, so this is what MFine's own team is posting about publicly — their topics, in their words.
The medical community just dropped a bombshell for women’s health. After a years-long global effort published in The Lancet, PCOS has officially been renamed to PMOS (Polyendocrine Metabolic Ovarian Syndrome). This isn't just a minor tweak in a textbook. It is a massive victory against a century of medical misdirection. Here is why this matters to every leader, HR professional, and executive on this platform: 1. The old name was a lie. For decades, focusing on "polycystic ovaries" led people to believe this was simply a reproductive or "fertility-only" issue. Forbes highlights that those "cysts" aren't even true cysts—they are simply pre-ovulatory follicles. Thousands of women without any cysts at all were left misdiagnosed, ignored, or told it was "all in their head." 2. It is a whole-body crisis, not just an ovary problem. By shifting the name to include "Polyendocrine" (hormones) and "Metabolic," medicine is finally catching up to reality. PMOS affects insulin resistance, heart health, energy levels, mental health, and weight management. It impacts how 1 in 8 women worldwide function every single day. 3. The impact on the workplace is massive. Chronic conditions like PMOS don't turn off when a woman logs into work. When a condition that drives severe fatigue, brain fog, and metabolic stress is minimized as "just a period issue," corporate wellness programs fail to provide the right support. Language shapes reality. When we rename a condition to accurately reflect its severity, we change how insurance covers it, how researchers fund it, and how employers accommodate it. Kudos to the global patient advocates and clinicians who fought for over a decade to make this change happen. To my network: Do you think changing a medical name will successfully shift how organizations view and support chronic conditions in workplace wellness? Let’s talk in the comments. 👇 #WomensHealth #Healthcare #Leadership #PMOS #PCOS #HormoneHealth #MetabolicHealth #InsulinResistance #WorkplaceWellness #EmployeeWellbeing #CorporateWellness
May 2026